Back
IDEXX Laboratories Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
57
IDXX
IDEXX Laboratories
Last Price:
511.26
Seasonality Move:
5.21%
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
0.51
Seasonality Move:
-14.79%
Buy
57
IDEXX Laboratories (IDXX)
is a Buy
Is IDEXX Laboratories a Buy, Sell or Hold?
- The current IDEXX Laboratories [IDXX] share price is $512.27. The Score for IDXX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- IDXX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IDXX Stock Price Chart
What is IDEXX Laboratories's stock price today?
-
The IDEXX Laboratories share price today is $512.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IDXX is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IDXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.78 | Buy |
Relative Strength Index (14 RSI): | 65.9 | Buy |
Chaikin Money Flow: | -300523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (476.32 - 499.16) | Buy |
Bollinger Bands (100): | (473.89 - 508.33) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 40.27 | Sell |
Chaikin Money Flow: | 161961 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Buy |
Bollinger Bands (100): | (0.64 - 3.4) | Sell |
IDXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 495.1 | Buy |
20-day SMA: | 487.8 | Buy |
50-day SMA: | 482.36 | Buy |
200-day SMA: | 513.67 | Sell |
8-day EMA: | 498.33 | Buy |
20-day EMA: | 490.03 | Buy |
50-day EMA: | 487.32 | Buy |
200-day EMA: | 495.91 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.93 | Sell |
200-day SMA: | 3.89 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 0.99 | Sell |
200-day EMA: | 8.5 | Sell |
IDEXX Laboratories Earnings Growth & IDXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.36 per share, an increase this year of $1.04 per share, and an increase next year of $1.33 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
IDEXX Laboratories Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |